COMMUNIQUÉS West-GlobeNewswire
-
Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress
12/11/2026 -
Hyro Achieves Oracle Validated: Oracle Health Endpoint Validation Expertise for Delivering Proven Agentic AI EHR Integration
12/11/2026 -
Artelo Biosciences Provides Business Update and Reports 2026 Third Quarter Financial Results
12/11/2026 -
Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects
12/11/2026 -
Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights
12/11/2026 -
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
12/11/2026 -
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
12/11/2026 -
Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2026 -
Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials
12/11/2026 -
123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health
12/11/2026 -
Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale
12/11/2026 -
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12/11/2026 -
Altimmune Announces Third Quarter 2026 Financial Results and Business Update
12/11/2026 -
Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16
12/11/2026 -
Immuneering Announces New Potentially Registrational Phase 2 Trial Evaluating Atebimetinib with Chemotherapy in Anaplastic Thyroid Cancer
12/11/2026 -
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update
12/11/2026 -
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
12/11/2026 -
Immuneering to Collaborate with Astellas on Clinical Studies of Investigational CLDN18.2 Programs in Combination with Atebimetinib for Pancreatic Cancer Patients
12/11/2026 -
Vor Bio Expands Strategic Partnership with RemeGen, Adding Next Generation, Long-Acting RC298 to BAFF/APRIL Franchise
12/11/2026
Pages